Zhu and his research team first analyzed the F proteins used in the development of four existing RSV vaccines—the commercially available Arexvy, mResvia and Abrysvo, and an experimental vaccine ...

Here, we describe the epidemiology of RSV, the RSV virion structure ... the small hydrophobic protein, the glyco (G) attachment protein and the fusion (F) protein. The F and G proteins are ...

High levels of neutralizing antibodies to RSV F protein have been shown to correlate with protection from RSV disease in infants and the elderly, and the clinical effectiveness of palivizumab and ...

Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my post earnings update for NVAX stock.

The human respiratory syncytial virus (HRSV) is one of the main agents of bronchiolitis ... since the two viruses have similar virion structure and genome organisation (5, 6). Like HCV, BVDV utilizes ...

Nirsevimab-resistant respiratory syncytial virus variants remain rare, but continued molecular surveillance is crucial. Read ...

BLB201 encodes the RSV F protein and uses a proprietary PIV5 vector, which is not known to cause human disease. PIV5 has been commonly administered to dogs as part of combination distemper/kennel ...

The ability to maintain target proteins’ native structure is essential because this ... of pre- and post-fusion conformations for the RSV antigen represented a breakthrough in RSV vaccine ...

TEDC1 and TEDC2, functions in generating centriolar triplet microtubules, and that this is crucial for the proper formation of centriolar subdomains and the stability of centrioles throughout the cell ...

From March 17, free immunisation for RSV will be made available to all newborn babies in NSW under an expanded program. From March 17, free immunisation for the virus will be made available to all ...